4//SEC Filing
Garg Vipin K 4
Accession 0001104659-25-008773
CIK 0001326190other
Filed
Feb 2, 7:00 PM ET
Accepted
Feb 3, 8:50 PM ET
Size
22.1 KB
Accession
0001104659-25-008773
Insider Transaction Report
Form 4
Garg Vipin K
Director
Transactions
- Exercise/Conversion
Common Stock, par value $0.0001
2025-02-01+16,545→ 351,645 total - Tax Payment
Common Stock, par value $0.0001
2025-02-02$6.64/sh−8,282$54,992→ 355,082 total - Exercise/Conversion
Restricted Stock Units
2025-01-30+26,775→ 53,550 total→ Common Stock, par value $0.0001 (26,775 underlying) - Exercise/Conversion
Restricted Stock Units
2025-02-01+16,545→ 0 total→ Common Stock, par value $0.0001 (16,545 underlying) - Exercise/Conversion
Restricted Stock Units
2025-02-02+18,950→ 18,950 total→ Common Stock, par value $0.0001 (18,950 underlying) - Exercise/Conversion
Common Stock, par value $0.0001
2025-01-30+26,775→ 342,696 total - Tax Payment
Common Stock, par value $0.0001
2025-02-01$6.64/sh−7,231$48,014→ 344,414 total - Exercise/Conversion
Common Stock, par value $0.0001
2025-02-02+18,950→ 363,364 total - Tax Payment
Common Stock, par value $0.0001
2025-01-30$7.00/sh−11,701$81,907→ 330,995 total - Award
Common Stock, par value $0.0001
2025-01-31$5.18/sh+4,105$21,264→ 335,100 total
Footnotes (7)
- [F1]Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested.
- [F2]Vesting transaction: Shares surrendered to the Issuer solely to cover taxes associated with vesting of RSUs.
- [F3]These shares were purchased due to participation by the reporting individual in the Issuer's 2019 Employee Stock Purchase Plan ("ESPP"). It pertains to the ESPP purchase period from August 1, 2024 through January 31, 2025.
- [F4]In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the Issuer's common stock on August 1, 2024.
- [F5]The RSUs vest in substantially equal annual installments over the 4 years following January 30, 2023, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date.
- [F6]The RSUs vest in substantially equal annual installments over the 4 years following February 1, 2021, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date.
- [F7]The RSUs vest in substantially equal annual installments over the 4 years following February 2, 2022, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date.
Documents
Issuer
Altimmune, Inc.
CIK 0001326190
Entity typeother
Related Parties
1- filerCIK 0001515813
Filing Metadata
- Form type
- 4
- Filed
- Feb 2, 7:00 PM ET
- Accepted
- Feb 3, 8:50 PM ET
- Size
- 22.1 KB